Ghaur, S.Y.; Grinderslev, P.B.; Leth-Møller, M.; Ovesen, P.G.; Fuglsang, J.; Fisker, S.; McIntyre, H.D.; Kampmann, U.
Diabetes Technology in Pregnant Women with Type 1 Diabetes—Distribution and Effects on Glycemic Regulation and Perinatal Outcomes. Reprod. Med. 2024, 5, 12-22.
https://doi.org/10.3390/reprodmed5010002
AMA Style
Ghaur SY, Grinderslev PB, Leth-Møller M, Ovesen PG, Fuglsang J, Fisker S, McIntyre HD, Kampmann U.
Diabetes Technology in Pregnant Women with Type 1 Diabetes—Distribution and Effects on Glycemic Regulation and Perinatal Outcomes. Reproductive Medicine. 2024; 5(1):12-22.
https://doi.org/10.3390/reprodmed5010002
Chicago/Turabian Style
Ghaur, Sara Yalda, Pernille Bundgaard Grinderslev, Magnus Leth-Møller, Per Glud Ovesen, Jens Fuglsang, Sanne Fisker, H. David McIntyre, and Ulla Kampmann.
2024. "Diabetes Technology in Pregnant Women with Type 1 Diabetes—Distribution and Effects on Glycemic Regulation and Perinatal Outcomes" Reproductive Medicine 5, no. 1: 12-22.
https://doi.org/10.3390/reprodmed5010002
APA Style
Ghaur, S. Y., Grinderslev, P. B., Leth-Møller, M., Ovesen, P. G., Fuglsang, J., Fisker, S., McIntyre, H. D., & Kampmann, U.
(2024). Diabetes Technology in Pregnant Women with Type 1 Diabetes—Distribution and Effects on Glycemic Regulation and Perinatal Outcomes. Reproductive Medicine, 5(1), 12-22.
https://doi.org/10.3390/reprodmed5010002
